ArticleNucleic acids research2026
CHK2 regulates MUS81-dependent DSBs in response to replication stress and BRCA2 deficiency.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
MUS81 is a structure-specific endonuclease that processes DNA intermediates during mitosis and in S-phase following replication stress. It plays a crucial role in cleaving deprotected reversed forks in BRCA2-deficient cells. However, how MUS81 is regulated during replication stress in human cells remains unknown. Our study reveals that CHK2 binds to the MUS8-EME2 complex in S-phase through the FHA domain and positively regulates the formation of DSBs in response to persistent or pathological replication stress. Mechanistically, our cellular and biochemical data identify a dual-site phosphorylation regulatory mechanism involving priming at the CDK2 site S95 followed by CHK2-dependent modification of the activatory site S97. Phosphorylation of MUS81 does not affect recruitment to the stalled forks but is crucial for the replication stress-dependent association with SLX4 in S-phase. At deprotected forks, in BRCA2-depleted cells, the CHK2-MUS81 complex assembles downstream of fork reversal and degradation, and CHK2-dependent phosphorylation is essential for replication fork recovery and viability. Together, our findings elucidate a novel regulatory mechanism of the MUS81 complex in S-phase and reveal a previously unrecognized role of the ATM-CHK2 axis in responding to persistent replication fork arrest or fork deprotection in the absence of BRCA2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.